Successful Nordic Pharmacoepidemiology Network (NORPEN) meeting in Oslo, Norway

Several PharmaSafe researchers attended the 11th NorPEN meeting last week. 

All the NorPEN 2018 attendees. 
Photo: Laila Torstveit. 
During two days 7-9 November 96 researchers in Pharmacoepidemiology across the Nordic countries met to exchange ideas and present the latest of their research on Drug utilization and Safety. The topic of the conference was “From the Womb to the Grave Life-Course Pharmacoepidemiology”. In total, 6 key note lectures, 1 round table debate, 9 presentations of Nordic collaborative studies/hot topics and 19 “Pharmacoepi slam” presentations were given. An important topic was also how to share sensitive data across the Nordic countries. A preconference courses on “genetic epidemiology” was attended by 23 participants. 
The conference will be in Denmark in 2019. 
More information can be found at the NorPEN webpage.

PharmaSafe researchers had several contributions at this year's conference: 

  • Johanne Naper Trønnes: Association of prenatal paracetamol exposure with neurodevelopment outcomes in five-year-old children and the role of unmeasured confounding (Pharmacoepi slam)
  • Mollie Wood: Causal mediation analysis in sibling designs: an application to estimated effects of prenatal antidepressant exposure and toddler anxiety and depressive symptoms mediated by gestational age at birth (Pharmacoepi slam)
  • Sarah Hjorth Andersen: How do we measure child neurodevelopment after prenatal exposure to psychotropics and analgesics? – A systematic literature review (Pharmacoepi slam)
  • Lene Maria Sundbakk: Prenatal exposure to benzodiazepines or z-hypnotics and child behavior problems at 5 years (Pharmacoepi slam) 
Photo: Lene Maria Sundbakk. 
Pre-meeting course: An introduction to genetic epidemiology. 
​​​​​​Photo: Lene Maria Sundbakk.
The conference booklet. 
Photo: Lene Maria Sundbakk
Published Nov. 15, 2018 9:49 AM - Last modified Nov. 15, 2018 10:35 AM